Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease.

Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease. J Clin Psychopharmacol. 2009 Oct; 29(5):484-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.